USP10 confers lenvatinib resistance in hepatocellular carcinoma by deubiquitinating the GPX2
Cellular Oncology · 14.05.2026 · 49 (4)
DOI: 10.1007/s13402-026-01210-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 14.05.2026. Verfasst von Cheng-Rui Zhong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery (Hepatobiliary Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 51065…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Drug Resistance, Neoplasm, Liver Neoplasms, Phenylurea Compounds. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Youth Foundation of China, China postdoctoral science foundation, National Key R&D Program of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery (Hepatobiliary Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China.
- Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China.
- Department of General Surgery, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, 518107, China.
- Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510700, China.
- Department of General Surgery, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, 518107, China. tangdi@sysush.com.
- Department of General Surgery (Hepatobiliary Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China. wanyunle@mail.sysu.edu.cn.
Förderung
- National Natural Science Youth Foundation of China
- China postdoctoral science foundation
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Key Clinical Discipline, the Open Fund of Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases
Zitieren
APA
Zhong, C. R., Qiu, Z., Tang, Y. J., Lin, Z., Tang, D., Wan, Y. L., & Li, G. L. (2026). USP10 confers lenvatinib resistance in hepatocellular carcinoma by deubiquitinating the GPX2. Cellular Oncology, 49(4). https://doi.org/10.1007/s13402-026-01210-9
Vancouver
Zhong CR, Qiu Z, Tang YJ, Lin Z, Tang D, Wan YL, et al. USP10 confers lenvatinib resistance in hepatocellular carcinoma by deubiquitinating the GPX2. Cellular Oncology. 2026;49(4). doi:10.1007/s13402-026-01210-9
BibTeX
@article{Zhong2026,
author = {Zhong, Cheng-Rui and Qiu, Zhiyu and Tang, Ya-Jun and Lin, Zhu and Tang, Di and Wan, Yun-Le and Li, Guo-Lin},
title = {USP10 confers lenvatinib resistance in hepatocellular carcinoma by deubiquitinating the GPX2},
journal = {Cellular Oncology},
year = {2026},
volume = {49},
number = {4},
doi = {10.1007/s13402-026-01210-9}
}
EUVIMED